The table below shows Aurinia Pharmaceuticals Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Revenue
$77.70M
$77.11M
$73.47M
$70.01M
$62.47M
$59.87M
Cost of revenue
$6.50M
-
$8.18M
$7.12M
$8.57M
-
Gross profit
-
-
-
-
-
-
R&D
$7.47M
-
$8.44M
$7.43M
$5.74M
-
AUPH annual revenue (10-K history)
Aurinia Pharmaceuticals Inc. reported annual revenue of $283.06M for fiscal year 2025. That is up 20.4% from $235.13M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $463.00K (FY 2018) to $283.06M. Figures come from the company's audited annual reports as filed with the SEC.